141 related articles for article (PubMed ID: 12509857)
1. The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction.
Bataller L; Wade DF; Graus F; Rosenfeld MR; Dalmau J
Ann Neurol; 2003 Jan; 53(1):123-7. PubMed ID: 12509857
[TBL] [Abstract][Full Text] [Related]
2. Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration.
de Graaff E; Maat P; Hulsenboom E; van den Berg R; van den Bent M; Demmers J; Lugtenburg PJ; Hoogenraad CC; Sillevis Smitt P
Ann Neurol; 2012 Jun; 71(6):815-24. PubMed ID: 22447725
[TBL] [Abstract][Full Text] [Related]
3. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
[TBL] [Abstract][Full Text] [Related]
4. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease.
Bernal F; Shams'ili S; Rojas I; Sanchez-Valle R; Saiz A; Dalmau J; Honnorat J; Sillevis Smitt P; Graus F
Neurology; 2003 Jan; 60(2):230-4. PubMed ID: 12552036
[TBL] [Abstract][Full Text] [Related]
5. A case report of plasmapheresis in paraneoplastic cerebellar ataxia associated with anti-Tr antibody.
Taniguchi Y; Tanji C; Kawai T; Saito H; Marubayashi S; Yorioka N
Ther Apher Dial; 2006 Feb; 10(1):90-3. PubMed ID: 16556143
[TBL] [Abstract][Full Text] [Related]
6. Induction of cytotoxic T lymphocytes specific for paraneoplastic cerebellar degeneration-associated antigen in vivo by DNA immunization.
Sakai K; Shirakawa T; Kitagawa Y; Li Y; Hirose G
J Autoimmun; 2001 Dec; 17(4):297-302. PubMed ID: 11771954
[TBL] [Abstract][Full Text] [Related]
7. Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate.
Greenlee JE; Clawson SA; Hill KE; Dechet CB; Carlson NG
J Neurol Sci; 2010 Apr; 291(1-2):74-8. PubMed ID: 20089262
[TBL] [Abstract][Full Text] [Related]
8. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
9. [Immunobiological approach to spinocerebellar degeneration--anti-Purkinje cell antibodies in paraneoplastic cerebellar degeneration].
Miyatake T
Rinsho Shinkeigaku; 1993 Dec; 33(12):1291-3. PubMed ID: 8174327
[TBL] [Abstract][Full Text] [Related]
10. Induction of humoral responses specific for paraneoplastic cerebellar degeneration-associated antigen by whole recombinant yeast immunization.
Saiki M; Sakai K; Saiki S; Kitagawa Y; Nakanishi M; Hirose G
J Autoimmun; 2005 May; 24(3):203-8. PubMed ID: 15848042
[TBL] [Abstract][Full Text] [Related]
11. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
Xia K; Saltzman JR; Carr-Locke DL
MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma.
Greene M; Lai Y; Baella N; Dalmau J; Lancaster E
JAMA Neurol; 2014 Aug; 71(8):1003-8. PubMed ID: 24935874
[TBL] [Abstract][Full Text] [Related]
13. Effect of a paraneoplastic cerebellar degeneration-associated neural protein on B-myb promoter activity.
Sakai K; Kitagawa Y; Saiki S; Saiki M; Hirose G
Neurobiol Dis; 2004 Apr; 15(3):529-33. PubMed ID: 15056460
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation by zinc-finger proteins Sp1 and MAZ involves interactions with the same cis-elements.
Song J; Ugai H; Nakata-Tsutsui H; Kishikawa S; Suzuki E; Murata T; Yokoyama KK
Int J Mol Med; 2003 May; 11(5):547-53. PubMed ID: 12684688
[TBL] [Abstract][Full Text] [Related]
15. [Cerebellar degeneration associated with anti-Tr antibodies without Hodgkin's disease. Four years follow-up].
Sánchez-Roy R; Pareja-Martínez A; Valero C; Perla C; Villarroya T; Bonet M; Graus F
Neurologia; 2004 Oct; 19(8):456-9. PubMed ID: 15470588
[TBL] [Abstract][Full Text] [Related]
16. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
Gal R; Sadikov E; Sulkes J; Klein B; Koren R
Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies.
Coesmans M; Smitt PA; Linden DJ; Shigemoto R; Hirano T; Yamakawa Y; van Alphen AM; Luo C; van der Geest JN; Kros JM; Gaillard CA; Frens MA; de Zeeuw CI
Ann Neurol; 2003 Mar; 53(3):325-36. PubMed ID: 12601700
[TBL] [Abstract][Full Text] [Related]
18. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
Storstein A; Krossnes BK; Vedeler CA
Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
[TBL] [Abstract][Full Text] [Related]
19. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
[TBL] [Abstract][Full Text] [Related]
20. Localization of immunoreactivity for deleted in colorectal cancer (DCC), the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents.
Osborne PB; Halliday GM; Cooper HM; Keast JR
Neuroscience; 2005; 131(3):671-81. PubMed ID: 15730872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
